Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Libonati

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosisT L Vollmer, J T Phillips, A D Goodman, et al.
Journal of Biological Regulators and Homeostatic Agents|April 25, 2018
Comparison of coronal leakage of different root canal filling techniques: an ex vivo studyA Libonati, V Di Taranto, C D Agostini, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 27, 2007
Natalizumab therapy for moderate to severe Crohn disease in adolescentsJeffrey S Hyams, David C Wilson, Adrian Thomas, et al.
Neurology|June 9, 2004
Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effectsP W O'Connor, A Goodman, A J Willmer-Hulme, et al.
The New England Journal of Medicine|January 3, 2003
A controlled trial of natalizumab for relapsing multiple sclerosisDavid H Miller, Omar A Khan, William A Sheremata, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosisT L Vollmer, J T Phillips, A D Goodman, et al.
Journal of Biological Regulators and Homeostatic Agents|April 25, 2018
Comparison of coronal leakage of different root canal filling techniques: an ex vivo studyA Libonati, V Di Taranto, C D Agostini, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 27, 2007
Natalizumab therapy for moderate to severe Crohn disease in adolescentsJeffrey S Hyams, David C Wilson, Adrian Thomas, et al.
Neurology|June 9, 2004
Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effectsP W O'Connor, A Goodman, A J Willmer-Hulme, et al.
The New England Journal of Medicine|January 3, 2003
A controlled trial of natalizumab for relapsing multiple sclerosisDavid H Miller, Omar A Khan, William A Sheremata, et al.
Pageof 3